Morning Edition · Thursday, June 11, 2026

Paulson Warns Against a United States and China Break as Beijing's Biotech Pushes Outward

A former United States Treasury secretary says distrust now poses a greater risk than trade imbalances, even as Chinese firms call their global expansion irreversible.

Henry Paulson, the former United States Treasury secretary, urged Washington and Beijing to manage their strategic competition before it widens into broader conflict. The South China Morning Post reported that Paulson sees deepening distrust, rather than trade imbalances, as the greater danger to the relationship between the world's two largest economies.

His warning arrives as the commercial split keeps widening. The same newspaper reported that Chinese biotechnology firms are pressing ahead with global expansion that industry insiders call irreversible, even as Washington rolls out investment restrictions and national-security measures intended to slow their advance.

Both accounts come from a Hong Kong outlet and reflect a view from the Chinese side of the divide. Read together, they describe a decoupling that policy is accelerating rather than preventing. Each new United States restriction pushes Chinese firms to build supply chains, capital sources and markets that route around the United States, which is the structural shift investors should track.

Veracity: Corroborated

85/100

If true, who benefits: Beijing and Chinese biotechnology firms benefit from the message that United States pressure is futile and that decoupling harms American business more than Chinese industry.
The nuance: Paulson's warning is genuine and consistent with his record, but the claim that Chinese biotech expansion is "irreversible" is industry and state-aligned framing carried by a Hong Kong outlet, not an independent measure of the restrictions' effect.

An open-source-intelligence read of how likely this story is true with its real nuance, not a judgment of any outlet. It assesses the claim, weighing independent and adversarial reporting.

What this means

The United States and China decoupling is moving from tariffs into capital and technology, and the response from Chinese industry is to globalize faster rather than retreat. For investors, the relevant question is no longer whether the two economies separate, but how quickly parallel systems in finance and technology take shape.

What to watch

New United States entity-list designations or investment curbs aimed at Chinese firms.
Where Chinese biotech and technology companies raise capital and list shares as United States access narrows.
Any high-level United States and China talks aimed at stabilizing the relationship.

Observations to monitor, not financial advice.

2 sources

Synthesized from: South China Morning Post (Diplomacy) · South China Morning Post (Business)